OBJECTIVE: To evaluate the relationship between insulin, the renin-aldosterone system and blood pressure in obese subjects. DESIGN AND METHODS: A cross sectional study of a group of severely obese normotensive subjects who were surgical candidates (n 39; mean BMI: 47.8 AE 1.4) and a group of hypertensive patients (n 57; mean BMI: 28.0 AE 0.7) twenty-nine of whom had BMI b 27. All subjects were studied after 15 days on a balanced diet. Insulin, plasma renin activity and aldosterone were measured. RESULTS: Fasting insulin, plasma renin activity and aldosterone were higher in severely obese normotensive subjects than in hypertensive subjects (respectively 32.3 AE 3.0 vs 13.1 AE 1.0 mUal, P 0.0001; 1.34 AE 0.22 vs 0.88 AE 0.12 ngamlah, P 0.04; 137.2 AE 16.2 vs 87.9 AE 12.1 pgaml, P 0.015). Insulin was related to BMI and to aldosterone both in normotensive and in hypertensive patients. CONCLUSION: Hyperinsulinemia itself does not determine hypertension; in some people it could play a vasodilator role in opposition to the renin-aldosterone system.
Introduction
Among the risk factors for arterial hypertension, obesity appears to be one of the most important in developed countries. 1 ± 3 Moreover in the general population, as well as in hypertensive people, body weight is usually positively related to blood pressure values. 4, 5 Hyperinsulinemia and insulin-resistance are often found in obesity, together with an alteration in renin-aldosterone system regulation, probably due to insulin itself. Hyperinsulinemia and insulin resistance have been postulated to be responsible for arterial hypertension in obese human beings. 6 ± 12 The aim of this work was to study the relationship between insulin and the renin-aldosterone system in severely obese normotensive people compared to hypertensive patients.
Methods
We studied 39 consecutive normotensive subjects with severe obesity (mean BMI: 47.8 AE 1.4 kgam 2 ), seen at our endocrine unit, who had been considered for a surgical approach for their obesity because of the dif®culties they encountered. The obese patients who were surgical candidates, came to our outpatient clinic for cardiovascular evaluation before the surgical approach.
They were free from other evident major pathological conditions including hypertension and had a history of obesity of more than ®ve years.
We also included in the study a group of mild to moderate hypertensive patients seen consecutively at the outpatient clinic in the same period (Table 1) .
For this study, we chose only those hypertensives without major cardiovascular or renal complications or associated morbid conditions (n 57): twenty-nine of these patients (50.8%) had a BMI above 27 and were considered as an obese hypertensive subgroup.
The subjects in the study gave informed consent. After at least 15 days washout from drugs and a balanced isoenergetic diet with controlled sodium intake (about 1800 kcal with 150 mEq of Na aday), blood pressure was measured (in an outpatient setting) at 8 am on the left arm using the auscultatory method with a mercury sphygmomanometer and appropriated cuff for arm diameter. Korotkoff phase I and V sounds were used for blood pressure recording.
Overnight fasting blood was then drawn from seated subjects to measure the concentration of plasma renin activity (radioimmunoassay: Technogenetics, Milan Italy), aldosterone (radioimmunoassay: Technogenetics, Milan Italy) and insulin.
Insulin was measured by means of radioimmunoassay (Incstar Co., Stillwater, MN, USA). This method, in our laboratory has 6.0% of coef®cient of variation betweenassay and sensitivity below 4 mUaml at 95% con®dence limits. The antiserum used shows the percentage of crossreactivity is less than 0.01% with human C-peptide and 28.0% with porcine proinsulin.
Results are given as means AE standard error of the mean. Statistical analysis was carried out using the ANOVA test and Spearman's rank correlation or linear regression where appropriate; a P-value less than 0.05 was considered signi®cant.
Results
Normotensive obese subjects who were surgical candidates showed signi®cantly higher values of fasting plasma insulin (32.3 AE 3.0 vs 13.1 AE 1.0 mUal, P 0.0001), basal plasma renin activity (1.34 AE 0.22 vs 0.88 AE 0.12 ngamlah, P 0.04) plasma basal aldosterone (137.2 AE 16.2 vs 87.9 AE 12.1 pgaml, P 0.015) and aldosteronearenin activity ratio (292.3 AE 74.0 vs 153.1 AE 20.4, p 0.03) compared with hypertensive patients.
The same difference was noted when obese patients who were surgical candidates were compared to the group of hypertensive patients with BMI above 27 kgam 2 ( Figure 1 ). In both the morbidity obese normotensive group, and hypertensive group, plasma insulin concentrations were correlated with BMI ( Figure 2) .
No signi®cant correlation was found between fasting plasma insulin and either systolic or diastolic blood pressure in either group.
No relationship was found between insulin and renin activity in all groups, whereas we noted a correlation Insulin and blood pressure in obesity G Andronico et al between insulin and plasma aldosterone which was independent of BMI in both obese normotensive patients who were surgical candidates and hypertensive subjects (respectively, rho 0.373, P 0.032, and rho 0.325, P 0.017) when non-parametric analysis was performed.
No difference was found in waistahip ratio between the groups in the study.
Discussion
Obesity is a condition which often occurs in patients with arterial hypertension, 13 adversely in¯uencing their prognosis so that weight loss is an important part of the treatment for the hypertensive state. 14 ± 16 Body weight is positively related to blood pressure values in hypertensive patients, in normotensive offspring of hypertensive patients 17 and also in normotensive subjects. 14, 18 Obese subjects are characterized by hyperinsulinemia and insulin-resistance, and these factors could be the cause of increased blood pressure. 19 Hyperinsulinemia, could indeed increase sympathetic activity 20, 21 and sodium reabsorption, 22 modify ion transport 23 ± 25 and stimulate proliferation of smooth-muscle cells, 26 mechanisms which promote and maintain high blood pressure values.
In obese subjects, hyperactivity of the renin-aldosterone system has been described. 27 Goodfriend et al 28 have shown a relationship between aldosterone and insulin concentrations and between plasma aldosterone concentrations and systolic blood pressure in obese subjects who were eating a high salt diet. These data have suggested insulin could have a role in hypertension in obese subjects through the reninaldosterone system.
In our work, severely obese subjects who were candidates for surgery have higher insulin and aldosterone concentrations than both lean and obese hypertensive patients, but they have normal blood pressure. This indicates that hyperinsulinemia does not necessarily lead to hypertension in obese people.
Moreover, similarly to Goodfriend et al, 28 we ®nd a relationship between insulin and plasma aldosterone in hypertensive patients, but the same correlation is also found in the group of severely obese but normotensive subjects. Hence it seems unlikely that high aldosterone is the link between insulin and hypertension.
Ferranini et al have shown in non diabetic normotensive obese subjects, a relatively low prevalence of insulin resistance, measured by the euglycemic clamp technique, in spite of insulin hypersecretion and hyperinsulinemia. 29 According to Ferranini, the difference between normotension and hypertension in obesity could be due to insulin resistance or to its producing factors rather than to hyperinsulinemia alone. In our work we did not perform euglycemic clamps so we cannot exclude the possibility that morbidity obese normotensive subjects were not insulin resistant despite very high plasma insulin concentrations.
The increased renin values we found in normotensive severely obese patients could be due to increased sympathetic stimulation which many authors have demonstrated in obese subjects: 30 this could explain, in part, the raised aldosterone plasma concentrations.
We cannot explain why, in our obese patients who were candidates for surgery, blood pressure remains in the normal range in spite of elevated plasma renin activity and aldosterone. It is feasible that in this group, insulin, in absence of a resistant state, has a strong vasodilator effect in opposition to the vasoconstrictor effect of the renin-aldosterone system stimulated by the sympathetic nervous system. Insulin infusion, during euglycemic hyperinsulinemic clamps, in spite of an increase of renin activity, is able to reduce total peripheral resistance 31 and to increase renal blood¯ow, an effect which is counterbalanced by contemporary norepinephrine infusion. 32 Our severely obese subjects could represent an unusual population protected by an unknown mechanism from hypertension. Nevertheless, our results demonstrate that insulin itself, or by stimulating aldosterone release, is not suf®cient to cause arterial hypertension. It is more likely that the alteration of insulin and the renin-aldosterone system is an effect of a disregulation of blood pressure control mechanisms. Insulin could play a role in counterbalancing the effect of the renin-aldosterone system on blood pressure.
